000			01818 a2200493 4500
005			20250516034445.0
264		0	_c20110906
008			201109s 0 0 eng d
022			_a1879-0712
024	7		_a10.1016/j.ejphar.2011.04.015 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhang, Yingbo
245	0	0	_aHydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis. _h[electronic resource]
260			_bEuropean journal of pharmacology _cJun 2011
300			_a438-44 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCarbon Tetrachloride _xadverse effects
650	0	4	_aChalcone _xanalogs & derivatives
650	0	4	_aChronic Disease _xprevention & control
650	0	4	_aCollagen Type I _xgenetics
650	0	4	_aGene Expression Regulation, Enzymologic _xdrug effects
650	0	4	_aHepatic Stellate Cells _xdrug effects
650	0	4	_aLiver Cirrhosis _xchemically induced
650	0	4	_aMale
650	0	4	_aMatrix Metalloproteinase 9 _xgenetics
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aQuinones _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSmad4 Protein _xmetabolism
650	0	4	_aTissue Inhibitor of Metalloproteinase-1 _xgenetics
650	0	4	_aTransforming Growth Factor beta1 _xmetabolism
700	1		_aGuo, Jia
700	1		_aDong, Hanying
700	1		_aZhao, Xuemei
700	1		_aZhou, Li
700	1		_aLi, Xueyan
700	1		_aLiu, Jicheng
700	1		_aNiu, Yingcai
773	0		_tEuropean journal of pharmacology _gvol. 660 _gno. 2-3 _gp. 438-44
856	4	0	_uhttps://doi.org/10.1016/j.ejphar.2011.04.015 _zAvailable from publisher's website
999			_c20800139 _d20800139